Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.93
+0.10001.46%
Post-market: 6.90-0.0300-0.43%19:50 EDT
Volume:6.04M
Turnover:42.23M
Market Cap:2.43B
PE:-15.80
High:7.09
Open:6.98
Low:6.88
Close:6.83
52wk High:9.75
52wk Low:2.76
Shares:351.12M
Float Shares:264.00M
Volume Ratio:0.72
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:9.58
PE(LYR):-11.55

Loading ...

Did New IBTROZI Quality‑of‑Life Data Just Shift Nuvation Bio’s (NUVB) Investment Narrative?

Simply Wall St.
·
May 29

Nuvation Bio held annual shareholder meeting

Reuters
·
May 28

Nuvation Bio to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 28

Nuvation Bio’s Ibtrozi shows improved quality of life in NSCLC trial

TIPRANKS
·
May 27

Nuvation Bio to present TRUST-II quality-of-life data for IBTROZI in ROS1+ lung cancer at ASCO 2026

Reuters
·
May 27

H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)

TIPRANKS
·
May 27

Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Universal Health (UHS)

TIPRANKS
·
May 26

How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?

Simply Wall St.
·
May 20

Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC

TIPRANKS
·
May 14

Nuvation Bio partners with Thermo Fisher for US manufacturing of IBTROZI

Reuters
·
May 14

Nuvation Bio to Collaborate With Thermo Fisher Scientific for U.S.-Based Manufacturing of Ibtrozi® for Ros1-Positive Non-Small Cell Lung Cancer

THOMSON REUTERS
·
May 14

Nuvation Bio says FDA accepts IBTROZI label update filing for ROS1+ NSCLC

Reuters
·
May 06

Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) With Updated Duration of Response in Advanced Ros1-Positive Non-Small Cell Lung Cancer

THOMSON REUTERS
·
May 06

Nuvation Bio Inc - FDA Accepts Supplemental Nda for Ibtrozi in Advanced Ros1+ Nsclc; Target Action Date Jan 4, 2027

THOMSON REUTERS
·
May 06

Nuvation Bio participates in Bank of America Securities Healthcare Conference fireside chat

Reuters
·
May 06

Stock Track | Nuvation Bio Soars 5.33% Intraday on Positive Analyst Coverage and Maintained Price Targets

Stock Track
·
May 05

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)

TIPRANKS
·
May 05

Nuvation Bio Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
May 05

Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss

MT Newswires Live
·
May 05

Nuvation Bio publishes corporate presentation on IBTROZI ROS1 lung cancer drug```

Reuters
·
May 05